Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Phase 1, Single-centre, Double-blind, Placebocontrolled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02935725

Organisation Name: Autifony Therapeutics Limited

Overal Status: Completed

Start Date: October 2016

Last Update: November 27, 2017

Lead Sponsor: Autifony Therapeutics Limited

Brief Summary: A Phase 1, Single-centre, Double-blind, Placebo controlled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants

Conditions:
  • Schizophrenia


Total execution time in seconds: 0.15373682975769